Long, Xi-Dai, Hong-Dong Huang, et al
There are currently six GLP-1 medications: Exenatide , taken twice daily: This was the first FDA-approved GLP-1
Diabetes Type 4: a Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent
Lifestyle intervention remains foundational and should be intensified concurrently with medication initiation
synthesizing cryoprotectant molecules and low-molecular-weight nitrogenous compounds
(Source: ASMBS, June 2025) A 2026 network meta-analysis of randomized controlled trials (30 trials, 20,015 patients) found metabolic/bariatric surgery achieved significantly greater reductions than GLP-1 receptor agonists in total weight loss (10.3 percentage points), BMI (4.5 kg/m), body weight (11.7 kg), waist circumference (12.6 cm), and HbA1c (0.5%) at under 104 weeks